neurexin II Inhibitors

The chemicals that can be categorized as neurexin II inhibitors do not directly inhibit the neurexin II protein but interact with various components of neuronal signaling and synaptic transmission where neurexin II is known to play a critical role. Neurexin II is a presynaptic protein that is involved in the formation and modulation of synapses, affecting neurotransmitter release and synaptic plasticity. Therefore, compounds that alter synaptic transmission can indirectly influence the function of neurexin II within the nervous system.

The first group of compounds, including tetrodotoxin, ω-conotoxin GVIA, and ω-agatoxin IVA, target ion channels that are essential for action potential propagation and neurotransmitter release at synapses. Tetrodotoxin, a potent inhibitor of voltage-gated sodium channels, can suppress neuronal excitability, which is fundamental for the activation of presynaptic neurexin II in initiating synaptic transmission. Similarly, the conotoxin and agatoxin peptides selectively inhibit specific subtypes of calcium channels, thereby modulating the influx of calcium ions that trigger synaptic vesicle exocytosis, a process where neurexin II is a critical component. Another set of molecules, including methyllycaconitine, phencyclidine, CNQX, D-AP5, bicuculline, and NBQX, act on various neurotransmitter receptors. For instance, methyllycaconitine's antagonistic effect on α7-nicotinic acetylcholine receptors and phencyclidine's antagonism of the NMDA receptor can alter synaptic plasticity and long-term potentiation (LTP), processes that are influenced by neurexin II-mediated interactions. CNQX and NBQX, which are antagonists for AMPA/kainate receptors, and D-AP5, another NMDA receptor antagonist, can change glutamatergic signaling, a pathway where neurexin II is involved in mediating synaptic strength and plasticity. Bicuculline's effect on GABA_A receptors can shift the balance of excitatory and inhibitory signaling in the brain, again impacting the functional context in which neurexin II operates.